The ExEm® Foam Inc. team was excited to meet with the renowned Dr. Steven R. Goldstein, M.D. this past week at NYU Langone Health, one of the nation’s premier academic medical centers located in the heart of Manhattan.
The goal of the visit was to introduce a new technology in tubal patency testing for women with known or suspected infertility. The innovative imaging technique offers a less complicated and less invasive alternative to laparoscopy and dye, the gold standard for diagnosing tubal patency. The outpatient tubal assessment is also associated with significantly lower pain scores as compared to the standard of care, X-ray hysterosalpingography (HSG), and does not require the use of radiation and iodine.
ExEm® Foam Inc. continues to visit and train healthcare professionals in facilities across the US. Contact us for more information if you are interested in using ExEm® Foam ((air polymer-type A) intrauterine foam) for your patients.
ExEm® Foam ((air polymer-type A) intrauterine foam), the only FDA-approved contrast agent for ultrasound tubal patency testing, is now available at select fertility clinics nationwide.
ExEm® Foam Inc. team visited NYU Langone Health to introduce new technology in tubal patency testing.
ExEm Foam Inc.